Skip to main navigation Skip to search Skip to main content

SWOG S0722: Phase II study of mTOR inhibitor everolimus (RAD001) in advanced Malignant Pleural Mesothelioma (MPM)

  • Sai Hong Ignatius Ou
  • , James Moon
  • , Linda L. Garland
  • , Philip C. Mack
  • , Joseph R. Testa
  • , Anne S. Tsao
  • , Antoniette J. Wozniak
  • , David R. Gandara

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'SWOG S0722: Phase II study of mTOR inhibitor everolimus (RAD001) in advanced Malignant Pleural Mesothelioma (MPM)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science